New Blood Test May Transform the Way Cancer Is Monitored and Treated (IMAGE)
Caption
This figure illustrates how the assay can be used clinically. In this patient, the data enabled the investigators to count the number of DNA molecules containing the KRAS G12V mutation and, therefore, count the number of molecules that came from the patient's tumor. The green dots represent molecules found to contain the mutation sequence, and the blue dots represent wild-type normal DNA molecules. The information was derived from less than a nanogram of cell-free DNA.
Credit
Hanlee P. Ji
Usage Restrictions
None
License
Licensed content